Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia
ClinicalTrials.gov study NCT06730256. IPD Sharing: NO. Countries: 1. Publications: 0.
Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01711528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07116616. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05000450. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT00884546. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06421675. IPD Sharing: NO. Countries: 1. Publications: 0.
Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT03952832. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3
ClinicalTrials.gov study NCT00866138. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT06062537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS
ClinicalTrials.gov study NCT06189833. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06297226. IPD Sharing: YES. Countries: 4. Publications: 0.
A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02230917. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)
ClinicalTrials.gov study NCT02206503. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
ClinicalTrials.gov study NCT01323751. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04280328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EMMA-1 (Erbitux for Multiple Myeloma)
ClinicalTrials.gov study NCT00368121. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Diagnosed Multiple Myeloma (MM) Transplant Ineligible Patients
ClinicalTrials.gov study NCT03001804. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05971056. IPD Sharing: NO. Countries: 1. Publications: 0.
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
ClinicalTrials.gov study NCT05271630. IPD Sharing: NO. Countries: 1. Publications: 0.
BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03943472. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.